TAF1 (TATA-box binding protein associated factor 1)

symbol
TAF1
locus group
protein-coding gene
location
Xq13.1
gene_family
K(lysine) acetyltransferases
alias symbol
NSCL2|TAFII250|KAT4|DYT3/TAF1
alias name
None
entrez id
6872
ensembl gene id
ENSG00000147133
ucsc gene id
uc004dzt.6
refseq accession
NM_004606
hgnc_id
HGNC:11535
approved reserved
1986-01-01
Xq13.1
ChineseEnglish

TATA-box binding protein associated factor 1 (TAF1) is a critical core subunit of the general transcription factor TFIID, belonging to the TBP-associated factor (TAF) family that collectively facilitates RNA polymerase II-mediated transcription initiation. As a multi-domain protein, TAF1 integrates several distinct functional activities, including histone acetyltransferase (HAT) and ubiquitin ligase capabilities, which allow it to remodel chromatin structure by acetylating histones to promote an open, transcriptionally accessible state, while also contributing to cell cycle regulation and DNA damage repair. Operating primarily at gene promoter regions, TAF1 synergizes with TATA-binding protein (TBP) and other TAF subunits to recognize core promoter elements such as the TATA box or Initiator (Inr), thereby stabilizing the pre-initiation complex (PIC) through conserved TAF domains that mediate essential protein-protein interactions. Disruptions in TAF1 function, whether through mutations that impair DNA binding or TFIID assembly, or through dysregulated expression levels, can lead to significant transcriptional dysregulation; for instance, overexpression may aberrantly activate oncogene transcription and drive tumorigenesis, particularly in contexts such as colorectal cancer, whereas underexpression compromises the transcription of essential housekeeping genes, disrupting basic cellular maintenance. Clinically, TAF1 mutations have been linked to X-linked intellectual disability syndromes, such as MRX33, and various malignancies, reflecting its role in maintaining the balance between cellular proliferation and differentiation. Given its high expression in neurons, TAF1 is particularly vital for neurodevelopment, where its functional integrity directly influences the transcriptional landscape of neural-specific genes, underscoring its broader importance in both developmental biology and disease pathogenesis.

Nucleotide sequence of TAF1:[NCBI]
Loading Gene Browser...
Protein Sequence
1MGPGCDLLLR TAATITAAAI MSDTDSDEDS AGGGPFSLAG
41FLFGNINGAG QLEGESVLDD ECKKHLAGLG ALGLGSLITE
81 LTANEELTG TDGALVNDEG WVRSTEDAVD YSDINEVAED
121ESRRYQQTMG SLQPLCHSDY DEDDYDADCE DIDCKLMPPP
161P PPPGPMKK DKDQDSITGE KVDFSSSSDS ESEMGPQEAT
201QAESEDGKLT LPLAGIMQHD ATKLLPSVTE LFPEFRPGKV
241LR FLRLFGP GKNVPSVWRS ARRKRKKKHR ELIQEEQIQE
281VECSVESEVS QKSLWNYDYA PPPPPEQCLS DDEITMMAPV
321ESK FSQSTG DIDKVTDTKP RVAEWRYGPA RLWYDMLGVP
361EDGSGFDYGF KLRKTEHEPV IKSRMIEEFR KLEENNGTDL
401LADE NFLMV TQLHWEDDII WDGEDVKHKG TKPQRASLAG
441WLPSSMTRNA MAYNVQQGFA ATLDDDKPWY SIFPIDNEDL
481VYGRW EDNI IWDAQAMPRL LEPPVLTLDP NDENLILEIP
521DEKEEATSNS PSKESKKESS LKKSRILLGK TGVIKEEPQQ
561NMSQPE VKD PWNLSNDEYY YPKQQGLRGT FGGNIIQHSI
601PAVELRQPFF PTHMGPIKLR QFHRPPLKKY SFGALSQPGP
641HSVQPLL KH IKKKAKMREQ ERQASGGGEM FFMRTPQDLT
681GKDGDLILAE YSEENGPLMM QVGMATKIKN YYKRKPGKDP
721GAPDCKYG E TVYCHTSPFL GSLHPGQLLQ AFENNLFRAP
761IYLHKMPETD FLIIRTRQGY YIRELVDIFV VGQQCPLFEV
801PGPNSKRAN THIRDFLQVF IYRLFWKSKD RPRRIRMEDI
841KKAFPSHSES SIRKRLKLCA DFKRTGMDSN WWVLKSDFRL
881PTEEEIRAMV SPEQCCAYY SMIAAEQRLK DAGYGEKSFF
921APEEENEEDF QMKIDDEVRT APWNTTRAFI AAMKGKCLLE
961VTGVADPTGC G EGFSYVKI PNKPTQQKDD KEPQPVKKTV
1001TGTDADLRRL SLKNAKQLLR KFGVPEEEIK KLSRWEVIDV
1041VRTMSTEQAR SG EGPMSKF ARGSRFSVAE HQERYKEECQ
1081RIFDLQNKVL SSTEVLSTDT DSSSAEDSDF EEMGKNIENM
1121LQNKKTSSQL SRE REEQER KELQRMLLAA GSAASGNNHR
1161DDDTASVTSL NSSATGRCLK IYRTFRDEEG KEYVRCETVR
1201KPAVIDAYVR IRTT KDEEF IRKFALFDEQ HREEMRKERR
1241RIQEQLRRLK RNQEKEKLKG PPEKKPKKMK ERPDLKLKCG
1281ACGAIGHMRT NKFCP LYYQ TNAPPSNPVA MTEEQEEELE
1321KTVIHNDNEE LIKVEGTKIV LGKQLIESAD EVRRKSLVLK
1361FPKQQLPPKK KRRVGT TVH CDYLNRPHKS IHRRRTDPMV
1401TLSSILESII NDMRDLPNTY PFHTPVNAKV VKDYYKIITR
1441PMDLQTLREN VRKRLYP SR EEFREHLELI VKNSATYNGP
1481KHSLTQISQS MLDLCDEKLK EKEDKLARLE KAINPLLDDD
1521DQVAFSFILD NIVTQKMM A VPDSWPFHHP VNKKFVPDYY
1561KVIVNPMDLE TIRKNISKHK YQSRESFLDD VNLILANSVK
1601YNGPESQYTK TAQEIVNVC YQTLTEYDEH LTQLEKDICT
1641AKEAALEEAE LESLDPMTPG PYTPQPPDLY DTNTSLSMSR
1681DASVFQDESN MSVLDIPSAT PEKQVTQEG EDGDGDLADE
1721EEGTVQQPQA SVLYEDLLMS EGEDDEEDAG SDEEGDNPFS
1761AIQLSESGSD SDVGSGGIRP K QPRMLQEN TRMDMENEES
1801MMSYEGDGGE ASHGLEDSNI SYGSYEEPDP KSNTQDTSFS
1841SIGGYEVSEE EEDEEEEEQR SG PSVLSQV HLSEDEEDSE
1881DFHSIAGDSD LDSDE
Structure predicted by AlphaFold DB(UniProt: P21675). Color indicates pLDDT confidence (dark blue = high, yellow/orange = low).
SNP variants of TAF1:           Showing partial SNPs
rs780049417       rs779733164       rs779641467       rs778306931       rs778220835       rs776596549       rs775583364       rs773104693       rs772949542       rs771804238       rs771716249       rs770747055       rs770279354       rs769669040       rs769581176       rs767122872       rs766474664      

Tissue expression of TAF1:    [UniProt]

Gene expression across tissues
Forward Primer
Forward Tm
Reverse Primer
Reverse Tm
Score
TGGTAAATGATGAAGGGTGG
58
TTTCATCTTCTGCCACCTC
58
TTCCTTCCCATTCAGAAAGC
58
CAGTTTGAGTCCATCCCTG
58
AGTATAATGGGTACATGTGCAC
58
ACAGACGTTCACAATCTCCT
59
CACAGACCCTATGGTGACG
60
GTGTGGAAAGGGTATGTATTTGG
60
TGGTAAATGATGAAGGGTGG
58
TTTCATCTTCTGCCACCTC
58
CTACCCATCTCGGGAAGAG
59
CCTTATGCCTATTCCATTGTAGG
59
AGAGCTATGGTGTCACCAG
59
CATAGCCAGCATCCTTCAG
58
ACAATCCTTTCTCTGCTATCCA
59
GTTGTTTGGGTCTTATTCCACC
60
CAGCTAATTGAGAGTGCGG
59
CTTCTTTGGAGGAAGCTGC
59
GCATATTCGAGACTTTCTACAGG
59
TTCCATTCGTATCCTCCGTG
60
Transcription Factors
Target Gene
Interaction Type
PubMed References
TAF1
AR
Activation
TAF1
CDKN1A
Activation
TAF1
LRIG2
Unknown
TAF1
SRC
Unknown
TAF1
TBP
Unknown

Subcellular localization of TAF1 (and its protein):

[UniProt]     [GenomeNet]

" d="M482.414,245.296c3.539,4.293,4.455,10.009,0.202,11 c-4.244,0.996-4.983-10.983-8.293-8.438c-5.271,4.08,9.834,12.271,5.144,17.287c-3.717,3.607-6.172-5.75-10.839-1.976 c-4.673,3.776,6.781,7.299,2.831,11.326c-4.354,4.045-6.979-1.449-9.837-5.517c-1.193-1.742-2.059-3.851-3.595-2.748 c-1.516,1.078-1.854,1.795-0.938,3.666c2.374,4.854,9.235,10.119,5.156,12.535c-5.636,3.346-5.044-8.871-9.426-7.574 c-4.388,1.291,2.557,10.66-1.245,11.141c-4.089,0.545-3.483-10.239-6.979-8.575c-2.522,1.206-0.929,3.071-0.938,4.899 c0.004,1.32-0.964,3.6-2.372,4.062c-3.593,1.171-8.544-1.065-10.251-3.59c-6.04-8.93,0.396-15.997,4.639-7.015 c3.023,4.642,5.182,0.834,2.839-2.219c-1.032-1.354-4.309-5.901-0.781-7.252c2.904-1.113,4.271,1.941,5.985,4.592 c2.61,4.016,5.485,0.117,3.031-3.414c-1.828-2.633-2.74-3.803,3.156-7.42c6.405-4.369,6.52,3.869,10.077,0.646 c2.309-1.832-4.783-5.149,0.06-8.995c2.896-2.293,5.18,6.207,7.961,3.516c3.523-2.737-7.717-7.369,0.117-11.736 C473.413,240.77,480.519,242.891,482.414,245.296z"/> Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
  • plasma membrane
  • cytoplasm
  • extracellular
  • golgi
  • vesicle
  • cytoskeleton
  • endoplasmic reticulum
  • nucleus
  • endosome
  • lysosome
  • mitochondrion

Gene Ontology (GO) terms for TAF1:

GO ID
Protein
Source DB
GO:0002039
P21675 (UniProtKB)
IPI
GO:0003713
P21675 (UniProtKB)
IDA
GO:0004402
P21675 (UniProtKB)
IDA
GO:0004674
P21675 (UniProtKB)
EXP
GO:0004674
P21675 (UniProtKB)
IDA
GO:0004674
P21675 (UniProtKB)
IDA
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005515
P21675 (UniProtKB)
IPI
GO:0005524
P21675 (UniProtKB)
IEA
GO:0005654
P21675 (UniProtKB)
IDA
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005654
P21675 (UniProtKB)
TAS
GO:0005669
P21675 (UniProtKB)
IDA
GO:0005669
P21675 (UniProtKB)
IDA
GO:0006352
P21675 (UniProtKB)
ISS
GO:0006366
P21675 (UniProtKB)
TAS
GO:0006367
P21675 (UniProtKB)
TAS
GO:0006367
P21675 (UniProtKB)
TAS
GO:0006368
P21675 (UniProtKB)
TAS
GO:0006974
P21675 (UniProtKB)
IC
GO:0007049
P21675 (UniProtKB)
IEA
GO:0008134
P21675 (UniProtKB)
IPI
GO:0016032
P21675 (UniProtKB)
IEA
GO:0016573
P21675 (UniProtKB)
IEA
GO:0017025
P21675 (UniProtKB)
IPI
GO:0018105
P21675 (UniProtKB)
IDA
GO:0018107
P21675 (UniProtKB)
IDA
GO:0032436
P21675 (UniProtKB)
IDA
GO:0043565
P21675 (UniProtKB)
ISS
GO:0045944
P21675 (UniProtKB)
IDA
GO:0045944
P21675 (UniProtKB)
IGI
GO:0046777
P21675 (UniProtKB)
TAS
GO:0046777
P21675 (UniProtKB)
IDA
GO:0051123
P21675 (UniProtKB)
ISS
GO:0060261
P21675 (UniProtKB)
ISS
GO:0070577
P21675 (UniProtKB)
IDA
GO:0071339
P21675 (UniProtKB)
IDA
GO:1901796
P21675 (UniProtKB)
TAS
GO:0044212
P21675 (UniProtKB)
ISS

microRNAs potentially regulating TAF1:     

String
BioGrid
IntAct
mentha
MINT
Reactome
Loading…
Interacting Gene Interaction Source/Score
Disease Score NofPmids NofSnps Source
Disease Score NofPmids NofSnps Source
Dystonia 3, Torsion, X-Linked 0.363800186 14 1 BeFree_CLINVAR_CTD_human_ORPHANET
Coronary Arteriosclerosis 0.004734064 2 0 GAD
Dystonia 0.002985861 11 0 BeFree
Meningococcal Infections 0.002367032 1 0 GAD
Pulmonary Thromboembolisms 0.002367032 1 0 GAD
Blood pressure finding 0.002367032 1 0 GAD
Angina Pectoris 0.002367032 1 0 GAD
Systemic arterial pressure 0.002367032 1 0 GAD
Deep Vein Thrombosis 0.002367032 1 0 GAD
Thrombotic Microangiopathies 0.002367032 1 0 GAD
Modest rescue of RBFOX1 splicing function attenuates Huntington's disease features.
Lozano-Muñoz D, Elorza A, Lucas-Santamaría M, Santos-Galindo M, Parras A, Lucas JJ Mol Med IF: 8.3 2026-04-02
Pinoresinol as a Potential c-Myc Complex Modulator: An In Silico Study.
Villanueva-Castillo A, Mancilla-Simbro C, Villa-Diaz F, Ramírez-Mata A, Pastelín-Rojas CF, Moreno-Mejía RS, Lucio-Castillo H, Castro-Bautista BL, Castillo-Sosa CG, Matamoros-González F, Cruz-Espinosa A, Abascal-Grajales A, Olea-Amezcua MA, Castillo EB, Hernández-Aragón LG, Noriega AE, Reyes Carmona SR, Quintana FU, Lobato Huerta S Curr Issues Mol Biol IF: 4.1 2026-08-17
Tau isoform imbalance and aggregation are pathological hallmarks of X-linked dystonia-parkinsonism.
Reyes CJ, Domingo A, Penney EB, Norenberg E, Han J, Murcar MG, Vaine CA, Bravo-Vasquez NA, Tran HD, Quittot N, Mate de Gerando A, Saez-Calveras N, Tak Y, Yadav R, Gao D, Reed S, Erdin S, Ramesh N, Wymann B, Held A, Monsanto RZ, Moran L, Wheeler H, Ruan YY, Griesman G, Field GA, Lee CZ, Crescencio G, Nolan M, Lemanski J, O'Keefe K, Jana B, Fernandez-Cerado C, Velasco-Andrada MS, Legarda GPA, Ganza-Bautista NG, Sy M, Hincher M, Petrozziello T, Kivisäkk P, Sadri-Vakili G, Muñoz EL, Ang MAC, Diesta CCE, Go C, Albers MW, Arnold S, Wainger BJ, Bennett RE, Diamond MI, Miller JW, Hyman BT, Sharma N, Ozelius LJ, Talkowski ME, Bragg DC, Lagier-Tourenne C medRxiv 2026-07-27
The Clinical, Genetic, Psychosocial, and Care Landscape of X-Linked Dystonia-Parkinsonism in Filipino Men: A Scoping Review.
Ramos MD, Manning J, Harris J, Adorno M, Marye R, Evangelista L Am J Mens Health IF: 2.4 None
Multi-omics analysis of arginine metabolism in ovarian cancer: A prognostic signature and GTF2F2-driven stromal remodeling.
Zhang D, Sheng J, Hu Y, Wang J, Sun Y, Zhou Y, Zhu X, Teng Y Transl Oncol IF: 4.9 2026-09-00
MSH3 is a genetic modifier of somatic repeat instability in X-linked dystonia parkinsonism.
Mejia Maza A, Hincher M, Correia K, Gillis T, Nishiyama A, Penney EB, Domingo A, Yadav R, Murcar MG, Villafria Mercado PD, Han JS, Norenberg EP, Fernandez-Cerado C, Legarda GP, Sy M, Muñoz EL, Ang MC, Diesta CCE, Go C, Sharma N, Bragg DC, Talkowski ME, MacDonald ME, Lee JM, Ozelius LJ, Wheeler VC Am J Hum Genet IF: 7.7 2026-01-08
TAF1 aggravates ferroptosis by promoting the ubiquitin-mediated degradation of nuclear GPX4.
Ye K, Gan M, Sun L, Chen C, Lai X, He Y, Zhu M, Jiang W, Zhang H J Zhejiang Univ Sci B IF: 5.7 2026-04-23
Correction of the molecular phenotype of X-linked Dystonia-Parkinsonism reveals a non-canonical function of BRD4.
Capponi S, Ehret S, Camgöz Z, Gather F, Vaine CA, Özyerli-Göknar E, Follo M, Bragg DC, Vogel T, Timmers HTM Nat Commun IF: 12.124 2026-05-05
Genome-wide CRISPR screen identifies TAF1C as an epigenetic determinant of lipid deposition via ACSL4-dependent ferroptosis in MASLD.
Gong Y, Chen J, Zhang F, Huang R, Mai L, Xu Y, Zhao W, Wei X, Zheng J, Liu X, Chen J J Adv Res IF: 17.1 2026-04-22

Loading comments...

Log in to post comments Log In Sign Up

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com